Al­ler­gan chief snaps up a ri­val biotech for $195M in cash, plus. Deal beefs up the aes­thet­ics pipeline

Just af­ter the start of the year, the crew of ex-Al­ler­gan ex­ecs that launched Bon­ti raised more than $15 mil­lion to back their de­vel­op­ment of …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.